Turn Biotechnologies expands the potential of its mRNA platform by licensing unique artificial niche technology. Turn Biotechnologies announced today that it …
Continue reading “Turn Bio expands mRNA platform with artificial niche tech”
Turn Biotechnologies licenses technology to unwind the effects of aging at a cellular level, with patents pending globally protect the …
Continue reading “Turn Bio announce worldwide IP for mRNA tech”
Exciting work out of the Sinclair lab shows that winding back the hands of the epigenetic clock with Yamanaka factors …
Continue reading “Resetting cells to a youthful regenerative state”
Co-founder of Longevity-focused investment firm shows you can target aging AND appeal to biotech investors. Founded in 2016, Berlin and …
Continue reading “Longevity investment: Apollo aims for the moon”
Not only is our biological age different from our chronological age, but it varies from organ to organ. Understanding why …
Continue reading “Outlived by our organs: different aging rates in the body”
Soaking up Longevity – a Stanford University team has rejuvenated aging human cells with a novel protein “bath” and formed …
AgeX Therapeutics and Lineage Cell Therapeutics awarded US patent for ‘Method of Generating Induced Pluripotent Stem Cells’. AgeX Therapeutics, Inc. and Lineage …
Continue reading “AgeX and Lineage granted pluripotent patent”
Synthetic embryo offers ethically transparent access to stem cells for use in organ growth and repair research. Three types of …
Continue reading “World’s first artificial embryo is Longevity gamechanger”
